DOI QR코드

DOI QR Code

Differentiation of antimicrobial toxicity and sepsis-induced disseminated intravascular coagulation in an orthopedic burn patient in India: a case report

  • Parampreet Singh Saini (Department of Burns and Plastic Surgery, All India Institute of Medical Sciences (AIIMS) Bilaspur) ;
  • Ankita Aggarwal (Department of Burns and Plastic Surgery, All India Institute of Medical Sciences (AIIMS) Bilaspur) ;
  • Tarunpreet Saini (Department of Pathology, All India Institute of Medical Sciences (AIIMS) Bilaspur)
  • Received : 2024.06.27
  • Accepted : 2024.09.19
  • Published : 2025.03.31

Abstract

Drug-induced thrombocytopenia, hemolytic anemia, and leukopenia are serious, and sometimes fatal, complications of common medications. These conditions are challenging to diagnose in patients with polytrauma injuries due to the presence of multiple potential etiologies. In such clinical scenarios, sepsis-induced disseminated intravascular coagulation is a more frequent diagnosis. The clinical manifestations of these conditions can be indistinguishable. We present the case of a 32-year-old man who sustained a left open grade 2 leg fracture and 18% to 20% second-degree superficial electrical flash burns on his right leg. Following primary management, skin testing for antibiotic sensitivity was performed, and prophylactic therapy with ceftriaxone, gentamycin, and metronidazole was initiated for the grossly contaminated wounds. On the second day of emergency admission, the patient developed hepatorenal dysfunction accompanied by severe thrombocytopenia (<30×103/mm3). The suspected antimicrobial agents were discontinued by the third day. Within 48 hours, the patient's hepatorenal function markedly improved; however, the blood dyscrasia progressed to severe pancytopenia over the next few days. Despite worsening parameters, the patient's vitals were maintained, and he exhibited no overt bleeding. On the fourth day, the patient developed opportunistic fungal bronchopneumonia, indicated by bilateral lower lobe infiltrates on chest x-ray and an elevated serum galactomannan level. He received supportive care, broad-spectrum antibiotics, and antifungal treatment, with a full recovery within 2 weeks. Antibiotic toxicity must be distinguished from other medical conditions to ensure appropriate management and a favorable prognosis.

Keywords

References

  1. ATLS Subcommittee; American College of Surgeons' Committee on Trauma; International ATLS working group. Advanced trauma life support (ATLS®): the ninth edition. J Trauma 2013;74:1363–6.
  2. Dossett AB, Hunt JL, Purdue GF, Schlegel JD. Early orthopedic intervention in burn patients with major fractures. J Trauma 1991;31:888–93. https://doi.org/10.1097/00005373-199107000-00002
  3. Markiewicz-Gospodarek A, Koziol M, Tobiasz M, Baj J, Radzikowska-Buchner E, Przekora A. Burn wound healing: clinical complications, medical care, treatment, and dressing types: the current state of knowledge for clinical practice. Int J Environ Res Public Health 2022;19:1338. https://doi.org/10.3390/ijerph19031338
  4. Zhang P, Zou B, Liou YC, Huang C. The pathogenesis and diagnosis of sepsis post burn injury. Burns Trauma 2021;9:tkaa047. https://doi.org/10.1093/burnst/tkaa047
  5. Curtis BR. Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms. Immunohematology 2014;30:55–65. https://doi.org/10.21307/immunohematology-2019-099
  6. Grossjohann B, Eichler P, Greinacher A, Santoso S, Kroll H. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells. Transfusion 2004;44:1033–40. https://doi.org/10.1111/j.1537-2995.2004.03378.x
  7. Reese JA, Li X, Hauben M, et al. Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood 2010;116:2127–33. https://doi.org/10.1182/blood-2010-03-276691
  8. Leach MF, Aubuchon JP. Frequency of thrombocytopenia associated with gentamicin therapy. Immunohematology 1999;15:167–70. https://doi.org/10.21307/immunohematology-2019-640
  9. Marini I, Uzun G, Jamal K, Bakchoul T. Treatment of drug-induced immune thrombocytopenias. Haematologica 2022;107:1264–77. https://doi.org/10.3324/haematol.2021.279484
  10. Iba T, Umemura Y, Watanabe E, et al. Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy. Acute Med Surg 2019;6:223–32. https://doi.org/10.1002/ams2.411
  11. Scully M, Hunt BJ, Benjamin S, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 2012;158:323–35. https://doi.org/10.1111/j.1365-2141.2012.09167.x
  12. Greenhalgh DG, Saffle JR, Holmes JH 4th, et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 2007;28:776–90. https://doi.org/10.1097/BCR.0b013e3181599bc9
  13. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–45. https://doi.org/10.1038/clpt.1981.154